• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Motor neuron disease in 2017: Progress towards therapy in motor neuron disease.

作者信息

Kiernan Matthew C

机构信息

Brain and Mind Centre, University of Sydney, New South Wales 2040, Australia.

出版信息

Nat Rev Neurol. 2018 Feb;14(2):65-66. doi: 10.1038/nrneurol.2017.186. Epub 2018 Jan 19.

DOI:10.1038/nrneurol.2017.186
PMID:29348545
Abstract
摘要

相似文献

1
Motor neuron disease in 2017: Progress towards therapy in motor neuron disease.2017年的运动神经元病：运动神经元病治疗进展
Nat Rev Neurol. 2018 Feb;14(2):65-66. doi: 10.1038/nrneurol.2017.186. Epub 2018 Jan 19.
2
Advances in therapy for spinal muscular atrophy: promises and challenges.脊髓性肌萎缩症治疗的进展：前景与挑战。
Nat Rev Neurol. 2018 Apr;14(4):214-224. doi: 10.1038/nrneurol.2018.4. Epub 2018 Feb 9.
3
Motor neuron disease: systematic reviews of treatment for ALS and SMA.运动神经元病：ALS 和 SMA 治疗的系统评价。
Br Med Bull. 2010;93:145-59. doi: 10.1093/bmb/ldp049. Epub 2009 Dec 15.
4
Cellular and molecular approaches to motor neuron therapy in amyotrophic lateral sclerosis and spinal muscular atrophy.细胞和分子方法治疗肌萎缩侧索硬化症和脊髓性肌萎缩症中的运动神经元。
Neurosci Lett. 2012 Oct 11;527(2):78-84. doi: 10.1016/j.neulet.2012.04.079. Epub 2012 May 8.
5
Edaravone for the treatment of amyotrophic lateral sclerosis.依达拉奉治疗肌萎缩侧索硬化。
Expert Rev Neurother. 2019 Mar;19(3):185-193. doi: 10.1080/14737175.2019.1581610. Epub 2019 Feb 27.
6
Edaravone May Prevent Ferroptosis in ALS.依达拉奉可能预防肌萎缩侧索硬化症中的铁死亡。
Curr Drug Targets. 2020;21(8):776-780. doi: 10.2174/1389450121666200220123305.
7
[Trypan red in therapy of amyotrophic lateral sclerosis and of myelopathic muscular atrophy].[锥虫红在肌萎缩侧索硬化症和脊髓病性肌萎缩症治疗中的应用]
Rass Int Clin Ter. 1955 Mar 31;35(6):197-206.
8
Edaravone for amyotrophic lateral sclerosis: barriers to access and lifeboat ethics.依达拉奉治疗肌萎缩侧索硬化症：获取药物的障碍与救生艇伦理
CMAJ. 2020 Mar 23;192(12):E319-E320. doi: 10.1503/cmaj.191236.
9
Efficacy and safety of edaravone in treatment of amyotrophic lateral sclerosis-a systematic review and meta-analysis.依达拉奉治疗肌萎缩侧索硬化症的疗效和安全性：系统评价和荟萃分析。
Neurol Sci. 2019 Feb;40(2):235-241. doi: 10.1007/s10072-018-3653-2. Epub 2018 Nov 27.
10
Human-induced pluripotent stem cells pave the road for a better understanding of motor neuron disease.人类诱导多能干细胞为更好地理解运动神经元疾病铺平了道路。
Hum Mol Genet. 2014 Sep 15;23(R1):R27-34. doi: 10.1093/hmg/ddu205. Epub 2014 May 12.

引用本文的文献

1
: A HERV Turn-On for Autoimmunity, Neurodegeneration, and Cancer?内源性逆转录病毒会引发自身免疫、神经退行性变和癌症吗？
Microorganisms. 2024 Sep 13;12(9):1890. doi: 10.3390/microorganisms12091890.
2
Amyotrophic Lateral Sclerosis and Pain: A Narrative Review from Pain Assessment to Therapy.肌萎缩侧索硬化症与疼痛：从疼痛评估到治疗的叙事性综述。
Behav Neurol. 2024 Mar 16;2024:1228194. doi: 10.1155/2024/1228194. eCollection 2024.
3
The Molecular Link Between TDP-43, Endogenous Retroviruses and Inflammatory Neurodegeneration in Amyotrophic Lateral Sclerosis: a Potential Target for Triumeq, an Antiretroviral Therapy.

本文引用的文献

1
Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy.依库珠单抗治疗婴儿型脊髓性肌萎缩症的疗效观察
N Engl J Med. 2017 Nov 2;377(18):1723-1732. doi: 10.1056/NEJMoa1702752.
2
Monitoring disease progression with plasma creatinine in amyotrophic lateral sclerosis clinical trials.在肌萎缩侧索硬化症临床试验中用血浆肌酸酐监测疾病进展。
J Neurol Neurosurg Psychiatry. 2018 Feb;89(2):156-161. doi: 10.1136/jnnp-2017-317077. Epub 2017 Oct 30.
3
Meta-analysis of pharmacogenetic interactions in amyotrophic lateral sclerosis clinical trials.
TDP-43、内源性逆转录病毒与肌萎缩性侧索硬化症炎症性神经变性的分子联系：抗逆转录病毒疗法特鲁瓦达（Triumeq）的潜在靶点。
Mol Neurobiol. 2023 Nov;60(11):6330-6345. doi: 10.1007/s12035-023-03472-y. Epub 2023 Jul 14.
4
A perspective on therapies for amyotrophic lateral sclerosis: can disease progression be curbed?肌萎缩侧索硬化症治疗方法的展望：疾病进展能否得到遏制？
Transl Neurodegener. 2021 Aug 10;10(1):29. doi: 10.1186/s40035-021-00250-5.
5
Risk Factors and Emerging Therapies in Amyotrophic Lateral Sclerosis.肌萎缩侧索硬化症的风险因素和新兴疗法。
Int J Mol Sci. 2019 May 28;20(11):2616. doi: 10.3390/ijms20112616.
6
Machine Learning in Amyotrophic Lateral Sclerosis: Achievements, Pitfalls, and Future Directions.肌萎缩侧索硬化症中的机器学习：成就、陷阱与未来方向。
Front Neurosci. 2019 Feb 28;13:135. doi: 10.3389/fnins.2019.00135. eCollection 2019.
7
Microhexagon gradient array directs spatial diversification of spinal motor neurons.微六边体梯度阵列指导脊髓运动神经元的空间多样化。
Theranostics. 2019 Jan 1;9(2):311-323. doi: 10.7150/thno.29755. eCollection 2019.
8
Interaction of Half Oxa-/Half -Platin Complex with Human Superoxide Dismutase and Induced Reduction of Neurotoxicity.半氧杂/半铂配合物与人超氧化物歧化酶的相互作用及神经毒性的诱导降低
ACS Med Chem Lett. 2018 Oct 1;9(11):1094-1098. doi: 10.1021/acsmedchemlett.8b00199. eCollection 2018 Nov 8.
9
Geographic Analysis of Motor Neuron Disease Mortality and Heavy Metals Released to Rivers in Spain.地理分析西班牙河流中释放的重金属与运动神经元病死亡率的关系。
Int J Environ Res Public Health. 2018 Nov 11;15(11):2522. doi: 10.3390/ijerph15112522.
10
Mast cells and neutrophils mediate peripheral motor pathway degeneration in ALS.肥大细胞和中性粒细胞介导 ALS 的周围运动通路变性。
JCI Insight. 2018 Oct 4;3(19):123249. doi: 10.1172/jci.insight.123249.
肌萎缩侧索硬化症临床试验中药效基因相互作用的荟萃分析。
Neurology. 2017 Oct 31;89(18):1915-1922. doi: 10.1212/WNL.0000000000004606. Epub 2017 Oct 4.
4
Cortical influences drive amyotrophic lateral sclerosis.皮层影响导致肌萎缩侧索硬化。
J Neurol Neurosurg Psychiatry. 2017 Nov;88(11):917-924. doi: 10.1136/jnnp-2017-315573. Epub 2017 Jul 14.
5
Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial.依达拉奉在明确诊断的肌萎缩侧索硬化症患者中的安全性和有效性：一项随机、双盲、安慰剂对照试验。
Lancet Neurol. 2017 Jul;16(7):505-512. doi: 10.1016/S1474-4422(17)30115-1. Epub 2017 May 15.
6
Genetic correlation between amyotrophic lateral sclerosis and schizophrenia.肌萎缩侧索硬化症与精神分裂症的遗传相关性。
Nat Commun. 2017 Mar 21;8:14774. doi: 10.1038/ncomms14774.
7
Safety and efficacy of ozanezumab in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled, phase 2 trial.奥扎尼单抗治疗肌萎缩侧索硬化症的安全性和有效性：一项随机、双盲、安慰剂对照、2 期临床试验。
Lancet Neurol. 2017 Mar;16(3):208-216. doi: 10.1016/S1474-4422(16)30399-4. Epub 2017 Jan 28.
8
The standard of care in amyotrophic lateral sclerosis: a centralised multidisciplinary clinic encounter sets a new benchmark for a uniquely challenging neurodegenerative disorder.肌萎缩侧索硬化症的护理标准：集中式多学科门诊会诊为这一极具挑战性的神经退行性疾病树立了新的标杆。
J Neurol Neurosurg Psychiatry. 2015 May;86(5):481-2. doi: 10.1136/jnnp-2014-309829. Epub 2014 Dec 30.
9
Amyotrophic lateral sclerosis.肌萎缩性侧索硬化症。
Lancet. 2011 Mar 12;377(9769):942-55. doi: 10.1016/S0140-6736(10)61156-7. Epub 2011 Feb 4.